Mark D. Eisner

19.8k total citations · 6 hit papers
179 papers, 14.3k citations indexed

About

Mark D. Eisner is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Mark D. Eisner has authored 179 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Pulmonary and Respiratory Medicine, 72 papers in Physiology and 34 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Mark D. Eisner's work include Asthma and respiratory diseases (52 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (50 papers) and Respiratory Support and Mechanisms (38 papers). Mark D. Eisner is often cited by papers focused on Asthma and respiratory diseases (52 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (50 papers) and Respiratory Support and Mechanisms (38 papers). Mark D. Eisner collaborates with scholars based in United States, United Kingdom and Canada. Mark D. Eisner's co-authors include Paul D. Blanc, Michael A. Matthay, Patricia Katz, Edward H. Yelin, Carlos Iribarren, Bruce Thompson, John R. Balmes, Polly E. Parsons, Laura Trupin and Lorraine B. Ware and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Mark D. Eisner

177 papers receiving 13.8k citations

Hit Papers

Lebrikizumab Treatment in Adults with Asthma 2002 2026 2010 2018 2011 2010 2002 2005 2011 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lebrikizumab Treatment in Adults with Asthma
    2011 1.1k citations Mark D. Eisner et al. profile →
  2. An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
    2010 679 citations Mark D. Eisner, N. Anthonisen et al. American Journal of Respiratory and Critical Care Medicine profile →
  3. Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome
    2002 563 citations Richard H Kallet, Jean‐François Pittet et al. profile →
  4. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*
    2005 547 citations Polly E. Parsons, Mark D. Eisner et al. Critical Care Medicine profile →
  5. Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
    2011 429 citations Mark D. Eisner et al. profile →
  6. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
    2016 350 citations Mark D. Eisner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Eisner United States 64 8.6k 5.4k 2.0k 1.9k 1.3k 179 14.3k
E. Haydn Walters Australia 72 11.3k 1.3× 9.3k 1.7× 1.7k 0.8× 1.2k 0.7× 1.3k 1.0× 525 19.2k
Pierre Ernst Canada 58 7.7k 0.9× 7.1k 1.3× 1.1k 0.5× 606 0.3× 639 0.5× 220 12.8k
Peter Lange Denmark 78 18.1k 2.1× 9.0k 1.6× 4.6k 2.3× 825 0.4× 545 0.4× 561 25.2k
Louis‐Philippe Boulet Canada 67 9.3k 1.1× 12.1k 2.2× 589 0.3× 987 0.5× 2.4k 1.9× 378 16.7k
Kevin B. Weiss United States 59 5.5k 0.6× 6.2k 1.1× 1.5k 0.8× 955 0.5× 149 0.1× 226 13.9k
Jerry A. Krishnan United States 54 6.0k 0.7× 4.0k 0.7× 1.0k 0.5× 476 0.3× 257 0.2× 228 10.4k
Ulrich Keil Germany 56 3.1k 0.4× 5.6k 1.0× 1.4k 0.7× 1.7k 0.9× 405 0.3× 172 14.5k
John E. Connett United States 63 7.6k 0.9× 6.1k 1.1× 1.3k 0.7× 627 0.3× 427 0.3× 240 15.1k
Bo Lundbäck Sweden 63 7.4k 0.9× 8.0k 1.5× 565 0.3× 1.7k 0.9× 411 0.3× 267 12.5k
Sanja Stanojevic Canada 48 12.1k 1.4× 5.2k 1.0× 1.4k 0.7× 869 0.5× 248 0.2× 217 15.5k

Countries citing papers authored by Mark D. Eisner

Since Specialization
Citations

This map shows the geographic impact of Mark D. Eisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Eisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Eisner more than expected).

Fields of papers citing papers by Mark D. Eisner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Eisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Eisner. The network helps show where Mark D. Eisner may publish in the future.

Co-authorship network of co-authors of Mark D. Eisner

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Eisner. A scholar is included among the top collaborators of Mark D. Eisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Eisner. Mark D. Eisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Shun, Jiong Wu, Jiang Jin, et al.. (2024). Efficacy and Safety of Roxadustat for Anemia in Patients Receiving Chemotherapy for Nonmyeloid Malignancies: A Randomized, Open-Label, Active-Controlled Phase III Study. Journal of Clinical Oncology. 43(2). 143–153. 5 indexed citations
2.
Caldwell, Jessica L., Jessica D. Clarke, Charlotte Smith, et al.. (2024). Restoring Atrial T-Tubules Augments Systolic Ca Upon Recovery From Heart Failure. Circulation Research. 135(7). 739–754. 3 indexed citations
3.
Paulin, Laura M., Gregory B. Diette, Paul D. Blanc, et al.. (2015). Occupational Exposures Are Associated with Worse Morbidity in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 191(5). 557–565. 74 indexed citations
4.
Calfee, Carolyn S., Michael A. Matthay, Mark D. Eisner, et al.. (2011). Active and Passive Cigarette Smoking and Acute Lung Injury after Severe Blunt Trauma. American Journal of Respiratory and Critical Care Medicine. 183(12). 1660–1665. 110 indexed citations
5.
Katz, Patricia, Anne Morris, Laura Julián, et al.. (2010). Onset of depressive symptoms among adults with asthma: results from a longitudinal observational cohort. Primary Care Respiratory Journal. 19(3). 223–230. 16 indexed citations
6.
Eisner, Mark D., N. Anthonisen, David Coultas, et al.. (2010). An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 182(5). 693–718. 679 indexed citations breakdown →
7.
Hsieh, S. Jean, Lorraine B. Ware, Mark D. Eisner, et al.. (2010). Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients*. Critical Care Medicine. 39(1). 40–45. 48 indexed citations
8.
Cooke, Colin R., Chirag V. Shah, Robert Gallop, et al.. (2009). A simple clinical predictive index for objective estimates of mortality in acute lung injury*. Critical Care Medicine. 37(6). 1913–1920. 42 indexed citations
9.
Liu, Kathleen D., Joseph E. Levitt, Hanjing Zhuo, et al.. (2008). Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 178(6). 618–623. 146 indexed citations
10.
Seeley, Eric J., Daniel F. McAuley, Mark D. Eisner, et al.. (2008). Predictors of mortality in acute lung injury during the era of lung protective ventilation. Thorax. 63(11). 994–998. 114 indexed citations
11.
Erickson, Sara E., Michael G. Shlipak, Greg S. Martin, et al.. (2008). Racial and ethnic disparities in mortality from acute lung injury*. Critical Care Medicine. 37(1). 1–6. 129 indexed citations
12.
Eisner, Mark D., Paul D. Blanc, Stephen Sidney, et al.. (2007). Body composition and functional limitation in COPD. Respiratory Research. 8(1). 7–7. 122 indexed citations
13.
McClintock, Dana, Lorraine B. Ware, Mark D. Eisner, et al.. (2006). Higher Urine Nitric Oxide is Associated with Improved Outcomes in Patients with Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 175(3). 256–262. 51 indexed citations
14.
Blanc, Paul D., Mark D. Eisner, John R. Balmes, et al.. (2005). Exposure to vapors, gas, dust, or fumes: Assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. American Journal of Industrial Medicine. 48(2). 110–117. 54 indexed citations
15.
Ware, Lorraine B., Mark D. Eisner, Bruce Thompson, Polly E. Parsons, & Michael A. Matthay. (2004). Significance of Von Willebrand Factor in Septic and Nonseptic Patients with Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 170(7). 766–772. 199 indexed citations
16.
Eisner, Mark D.. (2002). Environmental tobacco smoke exposure and pulmonary function among adults in NHANES III: impact on the general population and adults with current asthma.. Environmental Health Perspectives. 110(8). 765–770. 83 indexed citations
17.
Eisner, Mark D., Bruce Thompson, David Schoenfeld, Antonio Anzueto, & Michael A. Matthay. (2002). Airway Pressures and Early Barotrauma in Patients with Acute Lung Injury and Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 165(7). 978–982. 100 indexed citations
18.
Eisner, Mark D., Bruce Thompson, Leonard D. Hudson, et al.. (2001). Efficacy of Low Tidal Volume Ventilation in Patients with Different Clinical Risk Factors for Acute Lung Injury and the Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 164(2). 231–236. 199 indexed citations
19.
Blanc, Paul D., et al.. (2001). Alternative Therapies Among Adults With a Reported Diagnosis of Asthma or Rhinosinusitis. CHEST Journal. 120(5). 1461–1467. 152 indexed citations
20.
Eisner, Mark D., et al.. (2000). Predictors of cigarette smoking and smoking cessation among adults with asthma. American Journal of Public Health. 90(8). 1307–1311. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Haydn Walters Breakdown of academic impact, for papers by Pierre Ernst Breakdown of academic impact, for papers by Peter Lange Breakdown of academic impact, for papers by Louis‐Philippe Boulet Breakdown of academic impact, for papers by Kevin B. Weiss Breakdown of academic impact, for papers by Jerry A. Krishnan Breakdown of academic impact, for papers by Ulrich Keil Breakdown of academic impact, for papers by John E. Connett Breakdown of academic impact, for papers by Bo Lundbäck Breakdown of academic impact, for papers by Sanja Stanojevic
Rankless by CCL
2026